SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001181431-13-003030
Filing Date
2013-01-14
Accepted
2013-01-14 08:15:15
Documents
2
Period of Report
2013-01-08
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CHANGE OF AUDITOR rrd366480.htm 8-K 14716
2 LETTER FROM BDO TO THE SEC DATED JANUARY 9, 2012. rrd366480_39097.htm EX-16 758
  Complete submission text file 0001181431-13-003030.txt   16644
Mailing Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122 858-452-6600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 13526672
SIC: 2836 Biological Products, (No Diagnostic Substances)